These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16869151)

  • 1. Understanding ecstasy.
    Outslay MG
    JAAPA; 2006 Jul; 19(7):42-7. PubMed ID: 16869151
    [No Abstract]   [Full Text] [Related]  

  • 2. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G; Elston J; Garside R; Roome C; Taylor R; Younger P; Zawada A; Somerville M
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ecstasy, new psychotropic drugs].
    Djezzar S
    Soins Psychiatr; 2009; (262):35-7. PubMed ID: 19579485
    [No Abstract]   [Full Text] [Related]  

  • 4. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
    Huxster JK; Pirona A; Morgan MJ
    J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students.
    Brière FN; Fallu JS; Janosz M; Pagani LS
    J Epidemiol Community Health; 2012 Nov; 66(11):990-4. PubMed ID: 22516739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of psychiatric confounding in non-randomized studies of heavy ecstasy users.
    Krebs TS; Johansen PØ; Jerome L; Halpern JH
    Psychol Med; 2009 May; 39(5):876-8. PubMed ID: 19215629
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing the functional significance of ecstasy-related memory deficits using a virtual paradigm.
    Montgomery C; Hatton NP; Fisk JE; Ogden RS; Jansari A
    Hum Psychopharmacol; 2010; 25(4):318-25. PubMed ID: 20521322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amphetamine, ecstasy and cocaine. Clinical aspects of acute poisoning].
    Hedetoft C; Christensen HR
    Ugeskr Laeger; 1999 Dec; 161(50):6907-11. PubMed ID: 10643376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Poisoning with central nervous system stimulants. Amphetamine, ecstasy, cocaine and gamma-hydroxybutyrate].
    Christensen HR
    Ugeskr Laeger; 1999 Dec; 161(50):6899. PubMed ID: 10643372
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects and consequences of selected club drugs.
    Freese TE; Miotto K; Reback CJ
    J Subst Abuse Treat; 2002 Sep; 23(2):151-6. PubMed ID: 12220613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ecstasy-induced acute coronary syndrome: something to rave about.
    Hoggett K; McCoubrie D; Fatovich DM
    Emerg Med Australas; 2012 Jun; 24(3):339-42. PubMed ID: 22672176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Main illegal drugs consumed in France].
    Taéron C
    Rev Infirm; 2008 Dec; (146):47-9. PubMed ID: 19157197
    [No Abstract]   [Full Text] [Related]  

  • 17. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine toxicities: classical and emerging mechanisms.
    Yamamoto BK; Moszczynska A; Gudelsky GA
    Ann N Y Acad Sci; 2010 Feb; 1187():101-21. PubMed ID: 20201848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.
    Zhao H; Brenneisen R; Scholer A; McNally AJ; ElSohly MA; Murphy TP; Salamone SJ
    J Anal Toxicol; 2001; 25(4):258-69. PubMed ID: 11386639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.